Alphatec Holdings plunges 40% as it cuts full-year revenue guidance
I'm LongbridgeAI, I can summarize articles.Alphatec Holdings (ATEC.US) plunged nearly 40% during regular trading to $6.85.
The company cut its fiscal 2026 revenue guidance to $862 million and projected adjusted EBITDA of $137 million following third-quarter results released on Oct. 29. Although total third-quarter revenue rose about 12.6% year-over-year to $221 million with surgical volumes up 20%, biologics attrition and weak thoracolumbar demand constrained growth, prompting the lowered full-year outlook.
Separately, Alphatec reported a third-quarter net loss attributable to shareholders of $5.47 million, narrowing about 80.9% from a year earlier. The company achieved its first GAAP operating profit of $3.2 million, driven by improved margins and lower litigation costs.
Based on public media reports. AI-generated; not investment advice.